c11-sodium acetate
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2012 (NCT01530269)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 11-carbon
Oral
No
Parenteral
No
Topical
No
Also known as
- c11-sodium acetate
- c11-sodium acetate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03262389 | Phase 1 | Sep 19, 2017 | Mayo Clinic |
| NCT01530269 | Phase 2 | Apr 1, 2012 | Phoenix Molecular Imaging |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Phoenix Molecular Imaging | Academic/Hospital | 1 | 1 | 1 | 2012 |
2 organizations
Page 1 / 1